Bijou R Hunt1, Steve Whitman2, Marc S Hurlbert3. 1. Sinai Urban Health Institute, Room K443, Mount Sinai Hospital, 1500 South California Avenue, Chicago, IL 60608-1797, USA. Electronic address: Bijou.Hunt@sinai.org. 2. Sinai Urban Health Institute, Room K437, Mount Sinai Hospital, 1500 South California Avenue, Chicago, IL 60608-1797, USA. Electronic address: Steve.Whitman@sinai.org. 3. Avon Foundation Breast Cancer Crusade, 777 Third Avenue, New York, NY 10017, USA. Electronic address: Marc.Hurlbert@avonfoundation.org.
Abstract
INTRODUCTION: This paper presents race-specific breast cancer mortality rates and the corresponding rate ratios for the 50 largest U.S. cities for each of the 5-year intervals between 1990 and 2009. METHODS: The 50 largest cities in the U.S. were the units of analysis. Numerator data were abstracted from national death files where the cause was malignant neoplasm of the breast (ICD-9=174 and ICD-10=C50) for women. Population-based denominators were obtained from the U.S. Census Bureau for 1990, 2000, and 2010. To measure the racial disparity, we calculated non-Hispanic Black:non-Hispanic White rate ratios (RRs) and confidence intervals for each 5-year period. RESULTS: At the final time point (2005-2009), two RRs were less than 1, but neither significantly so, while 39 RRs were >1, 23 of them significantly so. Of the 41 cities included in the analysis, 35 saw an increase in the Black:White RR between 1990-1994 and 2005-2009. In many of the cities, the increase in the disparity occurred because White rates improved substantially over the 20-year study period, while Black rates did not. There were 1710 excess Black deaths annually due to this disparity in breast cancer mortality, for an average of about 5 each day. CONCLUSION: This analysis revealed large and growing disparities in Black:White breast cancer mortality in the U.S. and many of its largest cities during the period 1990-2009. Much work remains to achieve equality in breast cancer mortality outcomes.
INTRODUCTION: This paper presents race-specific breast cancer mortality rates and the corresponding rate ratios for the 50 largest U.S. cities for each of the 5-year intervals between 1990 and 2009. METHODS: The 50 largest cities in the U.S. were the units of analysis. Numerator data were abstracted from national death files where the cause was malignant neoplasm of the breast (ICD-9=174 and ICD-10=C50) for women. Population-based denominators were obtained from the U.S. Census Bureau for 1990, 2000, and 2010. To measure the racial disparity, we calculated non-Hispanic Black:non-Hispanic White rate ratios (RRs) and confidence intervals for each 5-year period. RESULTS: At the final time point (2005-2009), two RRs were less than 1, but neither significantly so, while 39 RRs were >1, 23 of them significantly so. Of the 41 cities included in the analysis, 35 saw an increase in the Black:White RR between 1990-1994 and 2005-2009. In many of the cities, the increase in the disparity occurred because White rates improved substantially over the 20-year study period, while Black rates did not. There were 1710 excess Black deaths annually due to this disparity in breast cancer mortality, for an average of about 5 each day. CONCLUSION: This analysis revealed large and growing disparities in Black:White breast cancer mortality in the U.S. and many of its largest cities during the period 1990-2009. Much work remains to achieve equality in breast cancer mortality outcomes.
Authors: Tracy A Battaglia; Julie S Darnell; Naomi Ko; Fred Snyder; Electra D Paskett; Kristen J Wells; Elizabeth M Whitley; Jennifer J Griggs; Anand Karnad; Heather Young; Victoria Warren-Mears; Melissa A Simon; Elizabeth Calhoun Journal: Breast Cancer Res Treat Date: 2016-07-18 Impact factor: 4.872
Authors: George Rust; Shun Zhang; Khusdeep Malhotra; Leroy Reese; Luceta McRoy; Peter Baltrus; Lee Caplan; Robert S Levine Journal: Cancer Date: 2015-04-23 Impact factor: 6.860
Authors: Blake C Alkire; Nakul P Raykar; Mark G Shrime; Thomas G Weiser; Stephen W Bickler; John A Rose; Cameron T Nutt; Sarah L M Greenberg; Meera Kotagal; Johanna N Riesel; Micaela Esquivel; Tarsicio Uribe-Leitz; George Molina; Nobhojit Roy; John G Meara; Paul E Farmer Journal: Lancet Glob Health Date: 2015-04-27 Impact factor: 26.763
Authors: Sachin Kumar Deshmukh; Sanjeev K Srivastava; Nikhil Tyagi; Aamir Ahmad; Ajay P Singh; Ahmed A L Ghadhban; Donna L Dyess; James E Carter; Kari Dugger; Seema Singh Journal: Carcinogenesis Date: 2017-08-01 Impact factor: 4.944
Authors: Richard B Warnecke; Richard T Campbell; Ganga Vijayasiri; Richard E Barrett; Garth H Rauscher Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-10-23 Impact factor: 4.254
Authors: John R Pamplin; Ezra S Susser; Pam Factor-Litvak; Bruce G Link; Katherine M Keyes Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2019-09-21 Impact factor: 4.328
Authors: Yamile Molina; Anne E Glassgow; Sage J Kim; Nerida M Berrios; Heather Pauls; Karriem S Watson; Julie S Darnell; Elizabeth A Calhoun Journal: Contemp Clin Trials Date: 2016-12-08 Impact factor: 2.226